Problems associated with the diagnostic evaluation of coronary artery disease (CAD) in women, including the underestimation of clinical coronary risk and decreased accuracy of noninvasive testing in women, have most likely contributed to the negative outcomes documented in women studied after myocardial infarction or coronary artery bypass grafting and in other high-risk subsets. This, together with the greater number of comorbid conditions seen in the generally older female CAD population, is responsible for the excessively high morbidity and mortality in women with CAD. More accurate diagnosis and aggressive treatment of women with suspected CAD should decrease this excess morbidity and mortality. Of the noninvasive tests used to diagnose CAD, myocardial perfusion imaging appears to be a particularly promising modality for use in women.
|Original language||English (US)|
|Number of pages||6|
|Journal||Journal of Myocardial Ischemia|
|Publication status||Published - Dec 1 1995|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine